ClinicalTrials.gg
CompletedNCT03412019Updated Mar 3, 2020Results posted

Music vs. No Music During Cesarean Delivery on Patient Satisfaction

An interventional study of Music in Patient Satisfaction, sponsored by Tufts Medical Center. Completed at 1 site in United States. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-03-03.

Sponsored by Tufts Medical Center · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 198 studies in Patient Satisfaction with a site in United States — 30 open to participants now, 35 under way, none of them phase 3. Patient Satisfaction · United States.

Enrollment
137th of 162
22 · median 100
Started
2018
with 11 others
No phase
137 of 198
23 open now
Registered
79th of 198
by date

Among the 198 studies in Patient Satisfaction with a site in United States, this one is the 137th largest by enrollment of the 162 interventional ones that give a count, is one of 12 that started in 2018, is one of 137 with no phase, and was the 79th registered.

Patient Satisfaction

877 studies on the registry are indexed under Patient Satisfaction; 202 are open to participants now.

Browse Patient Satisfaction studies →

Open to participants now

30 of the 198 studies in Patient Satisfaction with a site in United States are open now. Recruiting first, the newest first:

25 more — sign in →

All 30 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 99 Patient Satisfaction studies recruiting now, 61 (62%) set no upper age limit and 30 (30%) stop at 75 or younger; 14 take children under 18; 26 take healthy volunteers.

This study: 18 Years to 50 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 198 studies in Patient Satisfaction with a site in United States, or all of them as a file.
02

Study summary

Several studies have demonstrated that music can improve various outcomes during labor and delivery. However, many of these studies didn't measure satisfaction rate accurately. This study aim to assess patient satisfaction in the setting of music or no music during the cesarean delivery. The study will be conducted in the labor and delivery unit and the expected number to enroll and complete the study is 22.

Read the detailed description

Background:

Several studies have demonstrated that music can improve various outcomes during labor and delivery. In particular, patient satisfaction is often measured on a simple VAS scale, where 0 is no satisfaction and 10 is the highest satisfaction. However, patient satisfaction is a complex parameter to measure, and may be affected by a number of different factors. This study will be performed on the labor and delivery unit to assess patient satisfaction with a validated, reliable, 22-question survey in the setting of music or no music during the cesarean delivery.

Although "music" is an all-encompassing term that describes sound with different pitches and rhythms that comes together as a harmonious whole, not all music is the same. Using "music" for therapeutic purposes would be the equivalent of using "antibiotics" to cure an infection; it is too general of a term, and unlikely that such a general use of music would show a valid therapeutic benefit. However, a study demonstrated that specific selections of Mozart piano sonatas, which have a specific rhythm and mode, improve patient anxiety through a biochemical mechanism (changing the plasma levels of IL-6 and epinephrine). Therefore, in this study, the term "music" will specifically means the same Mozart sonatas as described in the prior study.

Objectives:

The objective of this study is to determine the effect of music on patient satisfaction and anxiety during cesarean delivery.

The hypothesis is that parturients exposed to music during cesarean delivery will have greater overall satisfaction and less anxiety.

Study Timelines:

  • Participation begins at the time of consultation for cesarean delivery on the day of surgery, where the co-investigator Dr. Dahlawi will approach the participants and ask them to sign the ICF, and it ends after the post-anesthesia check on postoperative day 1. After recruitment and consent, patients will be randomized using a computer-generated randomization scheme will be used to allocate patients to one of the arms of the study.
  • The two arms of the study are as follows:

    • Control group: baseline hemodynamics and anxiety screen; no music
    • Intervention group - Mozart: A study investigator will turn on a playlist of pre-selected Mozart music.
03

Conditions studied

  • Patient Satisfaction

Browse trials for

Keywords

  • Music
  • Patient Satisfaction
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: 18-50 years old
  • Scheduled for elective cesarean delivery
  • Nulliparity
  • Singleton pregnancy
  • Full term fetus (≥37.0 weeks gestational age)
  • Healthy fetus (no known congenital diseases at the time of surgery)
  • Requesting neuraxial anesthesia for the procedure
  • Able to provide

Exclusion criteria

Exclusion Criteria:

  • Patient refusal
  • Prior history of extensive abdominal surgery
  • Active labor
  • to neuraxial anesthesia
  • Uncorrected coagulopathy
  • Infection at the skin site of epidural placement
  • Increased intracranial pressure
  • Untreated hemodynamic instability
  • Known to local anesthetics (a.k.a. amide or ester allergy)
  • Patients with impaired hearing
  • Patient on anti-anxiolytic medication
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
22 participants (actual)

Study arms

  • No intervention
    Control group

    baseline hemodynamics and anxiety screen; no music. Satisfaction will be measured.

  • Experimental
    Intervention group - Mozart

    A study investigator will turn on a playlist of pre-selected Mozart music. Hemodynamics and anxiety screen. Satisfaction will be measured.

    Other: Music

Interventions

  • OtherMusic

    Selections of Mozart piano sonatas

06

What researchers measure

Primary outcomes

  1. Patient Satisfaction

    This outcome will be measured using Morgan's "Maternal Satisfaction Scale for Cesarean Section" (MSSCS). It is a 22-item questionnaire, each item have a Likert scale from 1-7 (1 =strongly disagree, 7=strongly agree), yielding a composite (total) score ranging 22-154, representing lowest to highest satisfaction. The questionnaire will be given to participants on post-operative day one during the hours of 8am-1pm.

    Time frame: 1 Day

Secondary outcomes

  1. Patient Anxiety

    Change in anxiety before and after surgery using a numeric rating scale from 0 (no anxiety at all) to 10 (greatest anxiety)

    Time frame: Perioperatively

  2. Hemodynamic Parameter (Mean Arterial Pressure, MAP)

    This is the post-procedure mean arterial pressure of the patients.

    Time frame: post procedure

07

Results

Posted Mar 3, 2020

Participant flow

Participant flow — Overall Study
MilestoneControl GroupIntervention Group
Started1111
Completed1010
Not completed11
Withdrew: Withdrawal by subject11

Outcome measures

PrimaryPatient Satisfaction

This outcome will be measured using Morgan's "Maternal Satisfaction Scale for Cesarean Section" (MSSCS). It is a 22-item questionnaire, each item have a Likert scale from 1-7 (1 =strongly disagree, 7=strongly agree), yielding a composite (total) score ranging 22-154, representing lowest to highest satisfaction. The questionnaire will be given to participants on post-operative day one during the hours of 8am-1pm.

Time frame:
1 Day
Reported as:
Mean · units on a scale
Patient Satisfaction
units on a scaleControl GroupIntervention Group
Patient Satisfaction120 ± 22.3116 ± 16.4
SecondaryPatient Anxiety

Change in anxiety before and after surgery using a numeric rating scale from 0 (no anxiety at all) to 10 (greatest anxiety)

Time frame:
Perioperatively
Reported as:
Mean · NRS scale (0-10)
Patient Anxiety
NRS scale (0-10)Control GroupIntervention Group
Patient Anxiety2.5 ± 2.62.7 ± 2.7
SecondaryHemodynamic Parameter (Mean Arterial Pressure, MAP)

This is the post-procedure mean arterial pressure of the patients.

Time frame:
post procedure
Reported as:
Mean · mmHg
Hemodynamic Parameter (Mean Arterial Pressure, MAP)
mmHgControl GroupIntervention Group
Hemodynamic Parameter (Mean Arterial Pressure, MAP)82.2 ± 24.880.4 ± 8.4

Adverse events

Collected over 24 hours. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Control Group0/11 (0%)0/11 (0%)0/11 (0%)
Intervention Group0/11 (0%)0/11 (0%)0/11 (0%)

Baseline characteristics

Parturients scheduled for cesarean delivery

Age, Continuous
Age, Continuous(years)Control GroupIntervention GroupTotal
Mean36.2 ± 4.232.1 ± 6.134.2 ± 5.5
Sex: Female, Male
Sex: Female, Male(Participants)Control GroupIntervention GroupTotal
Female101020
Male000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Control GroupIntervention GroupTotal
American Indian or Alaska Native000
Asian011
Native Hawaiian or Other Pacific Islander000
Black or African American000
White6612
More than one race000
Unknown or Not Reported437
08

Study locations

1 site
  • Tufts Medical Center
    Boston, Massachusetts 02111, United States
09

References and documents

Publications

  • Morgan PJ, Halpern S, Lo J. The development of a maternal satisfaction scale for caesarean section. Int J Obstet Anesth. 1999 Jul;8(3):165-70. doi: 10.1016/s0959-289x(99)80132-0. PubMed 15321139 ↗
  • Conrad C, Niess H, Jauch KW, Bruns CJ, Hartl W, Welker L. Overture for growth hormone: requiem for interleukin-6? Crit Care Med. 2007 Dec;35(12):2709-13. doi: 10.1097/01.ccm.0000291648.99043.b9. PubMed 18074473 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Will be shared upon reasonable request.

Supporting information: Study protocol

Time frame: Available for 1 year within publication.

Access criteria: Will need to write a formal request with reason for need to access the data

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2018 to primary completion in Aug 2019, 17 months.

Results were first posted in Mar 2020, 6 months after primary completion.

Of 368 non-industry interventional studies with no phase under Patient Satisfaction, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 17 months is above that.

Counting every sponsor, half of 370 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 12, 2018
First posted
Jan 26, 2018
StartActual
Feb 21, 2018
Primary completionActual
Aug 6, 2019
CompletionActual
Aug 6, 2019
Results first posted
Mar 3, 2020
Last update
Mar 3, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 3, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03412019
Responsible party
Sponsor
First posted
Jan 26, 2018
Start date
Feb 21, 2018
Primary completion
Aug 6, 2019
Completion
Aug 6, 2019
Results posted
Mar 3, 2020
Last update
Mar 3, 2020

Study contacts

Dan Drzymalski, MD
principal investigator · Tufts Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion